Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:Ubiquinone Oxidoreductase Subunit A7 (NDUFA7) is a nuclear-encoded accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). Complex I is the first and largest enzyme of the mitochondrial electron transport chain, responsible for transferring electrons from NADH to ubiquinone and pumping protons across the inner mitochondrial membrane to drive ATP synthesis (UniProt O95182). The NDUFA7 mRNA encodes a protein that is essential for the proper assembly and structural integrity of the Complex I holoenzyme (PMID: 29335508). Mutations in the NDUFA7 gene or alterations in its mRNA expression are associated with Mitochondrial Complex I deficiency, which can lead to severe metabolic and neurological disorders such as Leigh syndrome (PMID: 30245028). In the context of drug development, NDUFA7 is considered a component of the Complex I target for small-molecule inhibitors like metformin or IACS-010759, which are investigated for their ability to modulate metabolic pathways in cancer and metabolic diseases (NCBI Gene 4701). Furthermore, NDUFA7 mRNA levels serve as a critical biomarker for assessing mitochondrial function and the efficacy of therapies aimed at restoring oxidative phosphorylation.
Inhibition of mitochondrial Complex I electron transport; modulation of cellular NAD+/NADH ratio.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:Ubiquinone Oxidoreductase Subunit A7 (NDUFA7) (NDUFA7).